Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
2. Tronox Limited Ordinary Shares
47.9% sales growth and 71.4% return on equity
Tronox Holdings plc operates as a vertically integrated manufacturer of TiO2 pigment in South and Central America, Europe, the Middle East, Africa, and the Asia Pacific.
Tronox Limited Ordinary Shares's sales growth this year is expected to be 17.9% and 4% for next year.
Year-on-year quarterly revenue growth grew by 13%, now sitting on 2.76B for the twelve trailing months.
Tronox Limited Ordinary Shares's sales growth for the next quarter is 47.9%. The company's growth estimates for the present quarter and the next is a negative 3.4% and 1366.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 71.4%.
Volatility
Tronox Limited Ordinary Shares's last day, last week, and last month's current volatility was 4.51%, 2.90%, and 2.86%, respectively.
Tronox Limited Ordinary Shares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.88% (day), 4.91% (last week), and 4.68% (last month), respectively.
Tronox Limited Ordinary Shares's Stock Yearly Top and Bottom Value
Tronox Limited Ordinary Shares's stock is valued at $20.61 at 20:22 EST, below its 52-week high of $21.36 and way higher than its 52-week low of $4.66.
Tronox Limited Ordinary Shares's Moving Average
Tronox Limited Ordinary Shares's worth is way above its 50-day moving average of $18.38 and way higher than its 200-day moving average of $14.09.3. Littelfuse, Inc.
59.1% sales growth and 8.37% return on equity
Littelfuse, Inc. manufactures and sells circuit protection, power control, and sensing products in the Asia-Pacific, the Americas, and Europe.
Littelfuse, Inc.'s sales growth this year is expected to be 19.5% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 1.45B for the twelve trailing months.
Littelfuse, Inc.'s sales growth for the next quarter is 59.1%. The company's growth estimates for the current quarter and the next is 47.3% and 193%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.37%.
Volatility
Littelfuse, Inc.'s last day, last week, and last month's current volatility was 3.02%, 1.64%, and 1.37%, respectively.
Littelfuse, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.31% (day), 2.43% (last week), and 2.43% (last month), respectively.
Littelfuse, Inc.'s Stock Yearly Top and Bottom Value
Littelfuse, Inc.'s stock is valued at $275.94 at 20:22 EST, under its 52-week high of $287.92 and way higher than its 52-week low of $131.81.
Littelfuse, Inc.'s Moving Average
Littelfuse, Inc.'s value is above its 50-day moving average of $266.96 and way above its 200-day moving average of $248.15.4. Alexion Pharmaceuticals, Inc.
12.9% sales growth and 5.26% return on equity
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Alexion Pharmaceuticals, Inc.'s sales growth this year is expected to be 8% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 15%, now sitting on 6.07B for the twelve trailing months.
Alexion Pharmaceuticals, Inc.'s sales growth for the next quarter is 12.9%. The company's growth estimates for the ongoing quarter and the next is a negative 1.9% and 4.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.26%.
Volatility
Alexion Pharmaceuticals, Inc.'s last day, last week, and last month's current volatility was 0.44%, 0.76%, and 0.91%, respectively.
Alexion Pharmaceuticals, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.72% (day), 0.78% (last week), and 1.01% (last month), respectively.
Alexion Pharmaceuticals, Inc.'s Stock Yearly Top and Bottom Value
Alexion Pharmaceuticals, Inc.'s stock is valued at $166.92 at 20:22 EST, below its 52-week high of $167.77 and way above its 52-week low of $94.00.